doi:10.1371/journal.pone.0033944 Lederman RJ, Mendelsohn FO, Anderson RD, Saucedo JF, Tenaglia AN, Hermiller JB, Hillegass WB, Rocha-Singh K, Moon TE, Whitehouse MJ et al (2002) Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial
Viral hijack of NRP1 facilitates CNS invasion of SARS-CoV-2 through the blood brain barrier (BBB), and consequential neuro-cognitive symptoms such as anosmia, ageusia, headaches, confusion, delirium, and strokes in early COVID-19 647
The joint advisory from the four major medical societies outlines specific clinical priorities that many PCPs are not currently providing: resistance training prescriptions and protein intake recommendations of 1.01.2 grams per kilogram of body weight to protect lean mass, particularly in older or frail patients
Sweating or chills
J., Hoek, H